Press release
Global HIV-AIDS Testing Market
HIV-AIDS is a chronic disease caused by the human immunodeficiency virus (HIV). HIV virus damages human immune system, which results weakness of immune system and loss ability to fight with organism that causes disease. HIV-AIDS most often spread through unprotected sex with HIV infected person. In addition, HIV-AIDS can also be spread from infected mother to child during pregnancy, infected blood and sharing needles with someone who has HIV-AIDS. Some of the symptoms of HIV include slight fever, swollen glands, muscle aches, headaches and fatigue. HIV-AIDS has no cure but there are treatments which help to reduce AIDS deaths.
A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/3270
HIV-AIDS can be treated by nucleoside/ nucleotide reverse transcriptase inhibitor, integrase inhibitor, HIV-1 protease inhibitor, non-nucleoside reverse transcriptase inhibitor, pharmacokinetic enhancer and entry inhibitor. Some of the drugs for HIV -AIDS treatment include atripla, epzicom, prezista, truvada, kaletra, isentress, reyataz and viread. HIV testing and diagnostics include early detection, treatment swatching, On the basis of diagnosis HIV-AIDS market can be classified into HIV antibody assay, western blot, antigen-antibody immunoassay, HIV home-testing kit, rapid HIV antibody test, polymerase chain reaction test and HIV p24 antigen test.
Europe, followed by North America, has the largest market for HIV-AIDS testing due to affordability and accessibility of expensive tests for HIV-AIDS and innovations in drug therapies in this region. Asia is expected to show high growth rate in the HIV-AIDS testing market in next few years due to increasing number of HIV-AIDS population and increasing research activities for developing HIV drugs and vaccines in the region.
Increasing number of HIV patients, technological advancement in HIV-AIDS diagnosis, increasing incidence of infectious diseases, rise in research activities for developing HIV vaccines and lack of awareness about the modes of transmission of the virus are expected to drive the market for HIV-AIDS testing. In addition, increasing awareness about HIV aids treatment options available in the market and cost effective drug therapies for HIV is expected to drive the HIV-AIDS testing market. However, rapid replacement of HIV-AIDS drugs and therapies by new drugs and therapies and patient protection losses are some of the factors restraining the growth for global HIV-AIDS testing market.
Growing demographics and economies in the developing countries such as India and China is expected to lead the growth in HIV-AIDS testing market in Asia. In addition, rise in awareness about HIV-AIDS treatment and innovations in technologies related to HIV-AIDS testing are expected to offer new opportunity to global HIV-AIDS testing market. Companies involved in new product launch is one the recent trends have been observed in global HIV-AIDS testing market.
To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/3270
Some of the major companies operating in the global HIV AIDS market are Abbott Laboratories Inc., Hologic Inc., Siemens Healthcare Diagnostics Inc., Bio-Rad Laboratories Inc., Roche Diagnostics Inc. and Ortho-Clinical Diagnostics Inc.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global HIV-AIDS Testing Market here
News-ID: 486972 • Views: …
More Releases from Persistence Market Research Pvt. Ltd
Innovative Rehabilitation Technologies Drive Growth in Stroke Rehabilitation Mar …
Stroke Rehabilitation Market Size
The global stroke rehabilitation market size was valued at US$ 266.4 million in 2021 and is expected to grow at a CAGR of 9% from 2022 to 2032. Revenue generated from the sales of stroke rehabilitation solutions will surge to US$ 679.6 Million by the end of 2032.
The growth of the market is being driven by the increasing incidence of strokes, the growing demand for innovative rehabilitation…
Launch of New Laser-Based Devices by Key Players Fueling Growth of Global Aesthe …
Market Study on Aesthetic Lasers
The aesthetic lasers market reached US$2.8 billion in global revenue in 2021, and it will continue to expand quickly, with a value CAGR of 6.4%, to reach US$5.5 billion by the end of 2032. The growth of the market is being driven by the increasing demand for minimally invasive cosmetic procedures, rising disposable income, technological advancements, and growing medical tourism.
Stay Ahead with Market Intelligence Get Free…
Predictive Insights for Precision Medicine: The Global Biosimulation Market is S …
Biosimulation Market Research
The Global Biosimulation Market Size was valued at USD 2.9 billion in 2022 and is expected to reach USD 10.0 billion by 2030, registering a CAGR of 16.9% during the forecast period. The growth of the biosimulation market is being driven by the increasing use of biosimulation in a variety of applications, such as drug discovery, clinical trials, and toxicity prediction.
Market Overview
The biosimulation market has experienced rapid growth…
Wheelchair and Components Market: Growing Demand for Lightweight and Smart Wheel …
Wheelchair and Components Market
The global wheelchair and components market is projected to reach USD 17.9 billion by 2033, at a CAGR of 3.7% from 2022-2033. The growth of the market is driven by the increasing prevalence of disabilities, the rising geriatric population, and technological advancements in wheelchair design and manufacturing.
Click Here to Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/12961
The global wheelchair and components market has witnessed significant growth in…
More Releases for HIV
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments
Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV…
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Human Immunodeficiency Virus (HIV) Vaccines
1.1 Overview
1.2 Antiquity of HIV Vaccine
Need for the Development of HIV Vaccine
Primer of HIV inside the Body
3.1 Inclusion of HIV Virus into the System
3.2 Interaction of HIV with Host
3.3 Eradication of HIV Virus
HIV Vaccine Development Process
4.1 Introduction
…
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways…
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus.
Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral…
